EUVIMEDOpdag EUVIMED
Multizentrische Studie

C‐Reactive Protein Changes in Adult and Pediatric People With Cystic Fibrosis During Treatment of Pulmonary Exacerbations

Jonathan B Zuckerman, Alexandra C Hinton, Thomas Lahiri, Charlotte C Teneback, Shijing Jia, Joel Mermis, Deepika Polineni, Elliott Dasenbrook, Hossein Sadeghi, Emily DiMango, Rebecca Dezube, Natalie E West and 3 more

Pediatric Pulmonology · 2025

DOI: 10.1002/ppul.27487 ↗

At a glance

Multizentrische Studie in Pediatric Pulmonology, 2025. Written by Jonathan B Zuckerman and 14 co-authors. Institution: Maine Medical Center, Division of Pulmonary and Critical Care, Portland, Maine, USA. Major MEDLINE topics: Cystic Fibrosis, C-Reactive Protein, Anti-Bacterial Agents. 41 references. Funded by: NIGMS NIH HHS, This work was supported by the Cystic Fibrosis Foundation through a grant to J.B.Z. (ZUCKER18A01) and in part by the Northern New England Clinical and Translat….

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Objective

Although studies have examined changes in C‐reactive protein (CRP) during pulmonary exacerbations (PEX) in people with cystic fibrosis (PwCF), few have evaluated CRP profiles across age groups. Here, we characterize age‐related CRP responses to PEX treatment.

Methods

We measured CRP concentrations at the beginning and end of intravenous (IV) antibiotic therapy for PEX in 100 pediatric and 147 adult PwCF at 10 US CF Centers. We examined relationships between CRP and age, lung function, severity of PEX symptoms, and time to next PEX.

Results

CRP measured at initiation of IV antibiotic treatment for PEX was higher in adults than children, median 8 mg/L (IQR 4, 32) versus 5 mg/L (IQR 2, 10), respectively ( p < 0.001). There was a significant correlation between the initial CRP and drop in lung from baseline to the beginning of IV antibiotics in adults and children. Adjusted CRP dropped in response to PEX treatment more commonly in adults than in children (70% vs. 48%, respectively). The range of treatment responses was greater in adults, in those with higher symptom scores, and in those with more advanced lung disease. In adults elevated CRP at the end of treatment was also associated with incomplete recovery of lung function. CRP at the start of IV antibiotics was inversely related to time until the next PEX.

Conclusion

In children and adults with CF, CRP is increased at the initiation of IV antibiotic therapy for PEX and declines with treatment. The response is more pronounced in highly symptomatic adults with advanced lung disease.

Subjects

MeSH terms (MEDLINE)

Cystic FibrosisC-Reactive ProteinAnti-Bacterial AgentsHumansMaleFemaleChildAdultAdolescentYoung AdultAge FactorsSeverity of Illness IndexChild, PreschoolDisease Progression

Author keywords

C‐reactive proteincystic fibrosispulmonary exacerbation

Substances

C-Reactive ProteinAnti-Bacterial Agents

Authors and institutions

  • Maine Medical Center, Division of Pulmonary and Critical Care, Portland, Maine, USA.
  • Center for Outcomes and Research Evaluation, Maine Medical Center, Portland, Maine, USA.
  • Division of Pediatric Pulmonology, University of Vermont Medical Center, Burlington, Vermont, USA.
  • Division of Pulmonary and Critical Care, University of Vermont Medical Center, Burlington, Vermont, USA.
  • Division of Pulmonary and Critical Care, University of Michigan, Ann Arbor, Michigan, USA.
  • Division of Pulmonary and Critical Care, University of Kansas Medical Center, Kansas City, Missouri, USA.

Funding

  • NIGMS NIH HHS
  • This work was supported by the Cystic Fibrosis Foundation through a grant to J.B.Z. (ZUCKER18A01) and in part by the Northern New England Clinical and Translat…

Cite

APA

Zuckerman, J. B., Hinton, A. C., Lahiri, T., Teneback, C. C., Jia, S., Mermis, J., Polineni, D., Dasenbrook, E., Sadeghi, H., DiMango, E., Dezube, R., West, N. E., Zemanick, E. T., Samya, Z. N., & Gifford, A. H. (2025). C‐Reactive Protein Changes in Adult and Pediatric People With Cystic Fibrosis During Treatment of Pulmonary Exacerbations. Pediatric Pulmonology. https://doi.org/10.1002/ppul.27487

Vancouver

Zuckerman JB, Hinton AC, Lahiri T, Teneback CC, Jia S, Mermis J, et al. C‐Reactive Protein Changes in Adult and Pediatric People With Cystic Fibrosis During Treatment of Pulmonary Exacerbations. Pediatric Pulmonology. 2025. doi:10.1002/ppul.27487

BibTeX
@article{Zuckerman2025,
  author = {Zuckerman, Jonathan B and Hinton, Alexandra C and Lahiri, Thomas and Teneback, Charlotte C and Jia, Shijing and Mermis, Joel and Polineni, Deepika and Dasenbrook, Elliott and Sadeghi, Hossein and DiMango, Emily and Dezube, Rebecca and West, Natalie E and Zemanick, Edith T and Samya, Z Nasr and Gifford, Alex H},
  title = {C‐Reactive Protein Changes in Adult and Pediatric People With Cystic Fibrosis During Treatment of Pulmonary Exacerbations},
  journal = {Pediatric Pulmonology},
  year = {2025},
  doi = {10.1002/ppul.27487}
}
Start for free →